» Articles » PMID: 6766904

Virulence of Streptococcus Mutans: Revertants of Mutant C4

Overview
Journal Infect Immun
Date 1980 Jan 1
PMID 6766904
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Mutant C4, a poor plaque-forming mutant of Streptococcus mutans 6715-HSR, was employed to obtain isolates resembling the parent strain (a plaque former). Seventeen presumptive revertants, as identified by colonial morphology, were isolated from mutant C4 after enrichment cycles in a sucrose-glass beads medium. These isolates displayed properties which resembled the parent in ability to produce plaque, patterns of fermentation, and resistance to streptomycin. In a detailed study, five selected isolates were found to be similar to the parent type 6715-HSR with respect to content of the serotype antigen, sucrose- or dextran-induced cell aggregation, glucosyltransferase and adherence activities, and cariogenicity. Thus, in selection for revertants to parental colonial morphology, the pleiotropic changes in plaque formation, adherence, glycosyltransferase activity, and virulence demonstrated by C4 all concomitantly reverted to their parental phenotypes.

Citing Articles

Virulence-related physiological changes and antigenic variation in populations of Streptococcus mutans colonizing gnotobiotic rats.

Gibbons R, Qureshi J Infect Immun. 1980; 29(3):1082-91.

PMID: 7429627 PMC: 551242. DOI: 10.1128/iai.29.3.1082-1091.1980.


Virulence of Streptococcus mutans: characterization of a serotype g antigen-defective mutants and its revertants.

Otake S, Hirasawa M, Brown T, Kawabata Y, Kiyono H, Michalek S Infect Immun. 1981; 31(1):151-9.

PMID: 6452413 PMC: 351764. DOI: 10.1128/iai.31.1.151-159.1981.


Virulence of Streptococcus mutans: restoration of pathogenesis of a glucosyltransferase-defective mutant (C4).

Hirasawa M, Kiyono H, Shiota T, Hull R, Curtiss 3rd R, Michalek S Infect Immun. 1980; 27(3):915-21.

PMID: 6445880 PMC: 550862. DOI: 10.1128/iai.27.3.915-921.1980.


Chimeric streptococcal plasmids and their use as molecular cloning vehicles in Streptococcus sanguis (Challis).

Macrina F, Jones K, WOOD P J Bacteriol. 1980; 143(3):1425-35.

PMID: 6251030 PMC: 294526. DOI: 10.1128/jb.143.3.1425-1435.1980.


Role of Streptococcus mutans in human dental decay.

Loesche W Microbiol Rev. 1986; 50(4):353-80.

PMID: 3540569 PMC: 373078. DOI: 10.1128/mr.50.4.353-380.1986.

References
1.
Michalek S, Shiota T, Ikeda T, NAVIA J, McGhee J . Virulence of Streptococcus mutans: biochemical and pathogenic characteristics of mutant isolates. Proc Soc Exp Biol Med. 1975; 150(2):498-502. DOI: 10.3181/00379727-150-39064. View

2.
Schachtele C, Germaine G, Harlander S . Production of elevated levels of dextransucrase by a mutant of Streptococcus mutans. Infect Immun. 1975; 12(4):934-7. PMC: 415376. DOI: 10.1128/iai.12.4.934-937.1975. View

3.
Schachtele C, Staat R, Harlander S . Dextranases from oral bacteria: inhibition of water-insoluble glucan production and adherence to smooth surfaces by Streptococcus mutans. Infect Immun. 1975; 12(2):309-17. PMC: 415285. DOI: 10.1128/iai.12.2.309-317.1975. View

4.
RANTZ L, Randall E . Use of autoclaved extracts of hemolytic streptococci for serological grouping. Stanford Med Bull. 1955; 13(2):290-1. View

5.
FitzGerald R, JORDAN H, STANLEY H . Experimental caries and gingival pathologic changes in the gnotobiotic rat. J Dent Res. 1960; 39:923-35. DOI: 10.1177/00220345600390052701. View